The ophthalmic digital therapeutics (DTx) market is booming, projected to reach over $1.45 billion in 2025 with an 11.3% CAGR. Discover key trends, leading companies (Luminopia, NovaSight), and regional insights in this comprehensive market analysis. Explore the potential of DTx for age-related macular degeneration, glaucoma, and other eye diseases.

Our Clients

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.